 | • レポートコード：QFJ1-5517 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、新型コロナウイルス感染症特定抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注射）、用途別市場規模（軽症患者、重症患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・新型コロナウイルス感染症特定抗ウイルス薬の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症特定抗ウイルス薬の種類別市場規模と予測2016-2027（錠剤、注射） ・新型コロナウイルス感染症特定抗ウイルス薬の用途別市場規模と予測2016-2027（軽症患者、重症患者） ・新型コロナウイルス感染症特定抗ウイルス薬の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症特定抗ウイルス薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症特定抗ウイルス薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症特定抗ウイルス薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症特定抗ウイルス薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Novartis、Shanghai Zhongxisanwei、Teva、Zydus Cadila、Mylan、Apotex、Advanz Pharma、Sun Pharma、Kyung Poong、Ipca Laboratories、Hanlim Pharmaceutical、Bristol Laboratories、Bayer、Rising Pharmaceutical、Shanghai Pharma、Sichuan Sunny Hope、Guangzhou Baiyunshan Guanghua Pharmaceutical、CSPC Group、KPC Group、Jinghua Pharmaceutical Group、Zhongsheng Pharma、North China Pharmaceutical Group） ・結論 |
In 2021, the global Specific Antiviral Drugs for COVID-19 market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Specific Antiviral Drugs for COVID-19 status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Specific Antiviral Drugs for COVID-19 development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Specific Antiviral Drugs for COVID-19 Scope and Market Size
Specific Antiviral Drugs for COVID-19 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Specific Antiviral Drugs for COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tablet
Injection
Segment by Application
Mild Symptom Patient
Critically Ill Patient
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories
Bayer
Rising Pharmaceutical
Shanghai Pharma
Sichuan Sunny Hope
Guangzhou Baiyunshan Guanghua Pharmaceutical
CSPC Group
KPC Group
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Type (2021-2027)
1.2.2 Tablet
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Specific Antiviral Drugs for COVID-19 Market Share by Application (2021-2027)
1.3.2 Mild Symptom Patient
1.3.3 Critically Ill Patient
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Specific Antiviral Drugs for COVID-19 Market Size
2.2 Specific Antiviral Drugs for COVID-19 Market Size by Regions
2.2.1 Specific Antiviral Drugs for COVID-19 Growth Rate by Regions (2021-2027)
2.2.2 Specific Antiviral Drugs for COVID-19 Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Specific Antiviral Drugs for COVID-19 Revenue by Players (2020-2021)
3.2 Specific Antiviral Drugs for COVID-19 Key Players Headquaters and Area Served
3.3 Key Players Specific Antiviral Drugs for COVID-19 Product/Solution/Service
3.4 Date of Enter into Specific Antiviral Drugs for COVID-19 Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Specific Antiviral Drugs for COVID-19 Market Size by Type (2021-2027)
4.2 Global Specific Antiviral Drugs for COVID-19 Market Size by Application (2021-2027)
5 North America
5.1 North America Specific Antiviral Drugs for COVID-19 Market Forecast (2021-2027)
5.2 Specific Antiviral Drugs for COVID-19 Key Players in North America
5.3 North America Specific Antiviral Drugs for COVID-19 Market Size by Type
5.4 North America Specific Antiviral Drugs for COVID-19 Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Specific Antiviral Drugs for COVID-19 Market Forecast (2021-2027)
6.2 Specific Antiviral Drugs for COVID-19 Key Players in Europe
6.3 Europe Specific Antiviral Drugs for COVID-19 Market Size by Type
6.4 Europe Specific Antiviral Drugs for COVID-19 Market Size by Application
7 Japan
7.1 Japan Specific Antiviral Drugs for COVID-19 Market Forecast (2021-2027)
7.2 Specific Antiviral Drugs for COVID-19 Key Players in Europe
7.3 Japan Specific Antiviral Drugs for COVID-19 Market Size by Type
7.4 Japan Specific Antiviral Drugs for COVID-19 Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Specific Antiviral Drugs for COVID-19 Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Specific Antiviral Drugs for COVID-19 Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Specific Antiviral Drugs for COVID-19 Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Sanofi
9.1.1 Sanofi Company Details
9.1.2 Sanofi Description and Business Overview
9.1.3 Sanofi Specific Antiviral Drugs for COVID-19 Introduction
9.1.4 Sanofi Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.1.5 Sanofi Recent Development
9.2 Novartis
9.2.1 Novartis Company Details
9.2.2 Novartis Description and Business Overview
9.2.3 Novartis Specific Antiviral Drugs for COVID-19 Introduction
9.2.4 Novartis Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.2.5 Novartis Recent Development
9.3 Shanghai Zhongxisanwei
9.3.1 Shanghai Zhongxisanwei Company Details
9.3.2 Shanghai Zhongxisanwei Description and Business Overview
9.3.3 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Introduction
9.3.4 Shanghai Zhongxisanwei Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.3.5 Shanghai Zhongxisanwei Recent Development
9.4 Teva
9.4.1 Teva Company Details
9.4.2 Teva Description and Business Overview
9.4.3 Teva Specific Antiviral Drugs for COVID-19 Introduction
9.4.4 Teva Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.4.5 Teva Recent Development
9.5 Zydus Cadila
9.5.1 Zydus Cadila Company Details
9.5.2 Zydus Cadila Description and Business Overview
9.5.3 Zydus Cadila Specific Antiviral Drugs for COVID-19 Introduction
9.5.4 Zydus Cadila Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.5.5 Zydus Cadila Recent Development
9.6 Mylan
9.6.1 Mylan Company Details
9.6.2 Mylan Description and Business Overview
9.6.3 Mylan Specific Antiviral Drugs for COVID-19 Introduction
9.6.4 Mylan Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.6.5 Mylan Recent Development
9.7 Apotex
9.7.1 Apotex Company Details
9.7.2 Apotex Description and Business Overview
9.7.3 Apotex Specific Antiviral Drugs for COVID-19 Introduction
9.7.4 Apotex Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.7.5 Apotex Recent Development
9.8 Advanz Pharma
9.8.1 Advanz Pharma Company Details
9.8.2 Advanz Pharma Description and Business Overview
9.8.3 Advanz Pharma Specific Antiviral Drugs for COVID-19 Introduction
9.8.4 Advanz Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.8.5 Advanz Pharma Recent Development
9.9 Sun Pharma
9.9.1 Sun Pharma Company Details
9.9.2 Sun Pharma Description and Business Overview
9.9.3 Sun Pharma Specific Antiviral Drugs for COVID-19 Introduction
9.9.4 Sun Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.9.5 Sun Pharma Recent Development
9.10 Kyung Poong
9.10.1 Kyung Poong Company Details
9.10.2 Kyung Poong Description and Business Overview
9.10.3 Kyung Poong Specific Antiviral Drugs for COVID-19 Introduction
9.10.4 Kyung Poong Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.10.5 Kyung Poong Recent Development
9.11 Ipca Laboratories
9.11.1 Ipca Laboratories Company Details
9.11.2 Ipca Laboratories Description and Business Overview
9.11.3 Ipca Laboratories Specific Antiviral Drugs for COVID-19 Introduction
9.11.4 Ipca Laboratories Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.11.5 Ipca Laboratories Recent Development
9.12 Hanlim Pharmaceutical
9.12.1 Hanlim Pharmaceutical Company Details
9.12.2 Hanlim Pharmaceutical Description and Business Overview
9.12.3 Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Introduction
9.12.4 Hanlim Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.12.5 Hanlim Pharmaceutical Recent Development
9.13 Bristol Laboratories
9.13.1 Bristol Laboratories Company Details
9.13.2 Bristol Laboratories Description and Business Overview
9.13.3 Bristol Laboratories Specific Antiviral Drugs for COVID-19 Introduction
9.13.4 Bristol Laboratories Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.13.5 Bristol Laboratories Recent Development
9.14 Bayer
9.14.1 Bayer Company Details
9.14.2 Bayer Description and Business Overview
9.14.3 Bayer Specific Antiviral Drugs for COVID-19 Introduction
9.14.4 Bayer Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.14.5 Bayer Recent Development
9.15 Rising Pharmaceutical
9.15.1 Rising Pharmaceutical Company Details
9.15.2 Rising Pharmaceutical Description and Business Overview
9.15.3 Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Introduction
9.15.4 Rising Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.15.5 Rising Pharmaceutical Recent Development
9.16 Shanghai Pharma
9.16.1 Company Details
9.16.2 Shanghai Pharma Description and Business Overview
9.16.3 Shanghai Pharma Specific Antiviral Drugs for COVID-19 Introduction
9.16.4 Shanghai Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.16.5 Shanghai Pharma Recent Development
9.17 Sichuan Sunny Hope
9.17.1 Sichuan Sunny Hope Company Details
9.17.2 Sichuan Sunny Hope Description and Business Overview
9.17.3 Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Introduction
9.17.4 Sichuan Sunny Hope Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.17.5 Sichuan Sunny Hope Recent Development
9.18 Guangzhou Baiyunshan Guanghua Pharmaceutical
9.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
9.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
9.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Introduction
9.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.18.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
9.18 CSPC Group
.1 CSPC Group Company Details
.2 CSPC Group Description and Business Overview
.3 CSPC Group Specific Antiviral Drugs for COVID-19 Introduction
.4 CSPC Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
.5 CSPC Group Recent Development
9.20 KPC Group
9.20.1 KPC Group Company Details
9.20.2 KPC Group Description and Business Overview
9.20.3 KPC Group Specific Antiviral Drugs for COVID-19 Introduction
9.20.4 KPC Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.20.5 KPC Group Recent Development
9.21 Jinghua Pharmaceutical Group
9.21.1 Jinghua Pharmaceutical Group Company Details
9.21.2 Jinghua Pharmaceutical Group Description and Business Overview
9.21.3 Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Introduction
9.21.4 Jinghua Pharmaceutical Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.21.5 Jinghua Pharmaceutical Group Recent Development
9.22 Zhongsheng Pharma
9.22.1 Zhongsheng Pharma Company Details
9.22.2 Zhongsheng Pharma Description and Business Overview
9.22.3 Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Introduction
9.22.4 Zhongsheng Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.22.5 Zhongsheng Pharma Recent Development
9.23 North China Pharmaceutical Group
9.23.1 North China Pharmaceutical Group Company Details
9.23.2 North China Pharmaceutical Group Description and Business Overview
9.23.3 North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Introduction
9.23.4 North China Pharmaceutical Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2020-2021)
9.23.5 North China Pharmaceutical Group Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Tablet
Table 3. Key Players of Injection
Table 4. Global Specific Antiviral Drugs for COVID-19 Market Size Growth by Application (2021-2027) (US$ Million)
Table 5. Global Specific Antiviral Drugs for COVID-19 Market Size by Regions (2021-2027) (US$ Million)
Table 6. Global Specific Antiviral Drugs for COVID-19 Market Share by Regions (2021-2027)
Table 7. Market Top Trends
Table 8. Market Use Cases
Table 9. Global Specific Antiviral Drugs for COVID-19 Revenue by Players (2020-2021) (US$ Million)
Table 10. Global Specific Antiviral Drugs for COVID-19 Market Share by Players (2020-2021)
Table 11. Key Players Headquarters and Area Served
Table 12. Key Players Specific Antiviral Drugs for COVID-19 Product Solution and Service
Table 13. Date of Enter into Specific Antiviral Drugs for COVID-19 Market
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Global Specific Antiviral Drugs for COVID-19 Market Size by Type (2021-2027) (US$ Million)
Table 16. Global Specific Antiviral Drugs for COVID-19 Market Size Share by Type (2021-2027)
Table 17. Global Specific Antiviral Drugs for COVID-19 Market Size by Application (2021-2027) (US$ Million)
Table 18. Global Specific Antiviral Drugs for COVID-19 Market Size Share by Application (2021-2027)
Table 19. North America Key Players Specific Antiviral Drugs for COVID-19 Revenue (2020-2021) (US$ Million)
Table 20. North America Key Players Specific Antiviral Drugs for COVID-19 Market Share (2020-2021)
Table 21. North America Specific Antiviral Drugs for COVID-19 Market Size by Type (2021-2027) (US$ Million)
Table 22. North America Specific Antiviral Drugs for COVID-19 Market Share by Type (2021-2027)
Table 23. North America Specific Antiviral Drugs for COVID-19 Market Size by Application (2021-2027) (US$ Million)
Table 24. North America Specific Antiviral Drugs for COVID-19 Market Share by Application (2021-2027)
Table 25. Europe Key Players Specific Antiviral Drugs for COVID-19 Revenue (2020-2021) (US$ Million)
Table 26. Europe Key Players Specific Antiviral Drugs for COVID-19 Market Share (2020-2021)
Table 27. Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2021-2027) (US$ Million)
Table 28. Europe Specific Antiviral Drugs for COVID-19 Market Share by Type (2021-2027)
Table 29. Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2021-2027) (US$ Million)
Table 30. Europe Specific Antiviral Drugs for COVID-19 Market Share by Application (2021-2027)
Table 31. Japan Key Players Specific Antiviral Drugs for COVID-19 Revenue (2020-2021) (US$ Million)
Table 32. Japan Key Players Specific Antiviral Drugs for COVID-19 Market Share (2020-2021)
Table 33. Japan Specific Antiviral Drugs for COVID-19 Market Size by Type (2021-2027) (US$ Million)
Table 34. Japan Specific Antiviral Drugs for COVID-19 Market Share by Type (2021-2027)
Table 35. Japan Specific Antiviral Drugs for COVID-19 Market Size by Application (2021-2027) (US$ Million)
Table 36. Japan Specific Antiviral Drugs for COVID-19 Market Share by Application (2021-2027)
Table 37. Key Players in China
Table 38. Key Players in Southeast Asia
Table 39. Key Players in India
Table 40. Sanofi Company Details
Table 41. Sanofi Description and Business Overview
Table 42. Sanofi Specific Antiviral Drugs for COVID-19 Product
Table 43. Sanofi Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 44. Sanofi Recent Development
Table 45. Novartis Company Details
Table 46. Novartis Description and Business Overview
Table 47. Novartis Specific Antiviral Drugs for COVID-19 Product
Table 48. Novartis Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 49. Novartis Recent Development
Table 50. Shanghai Zhongxisanwei Company Details
Table 51. Shanghai Zhongxisanwei Description and Business Overview
Table 52. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Product
Table 53. Shanghai Zhongxisanwei Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 54. Shanghai Zhongxisanwei Recent Development
Table 55. Teva Company Details
Table 56. Teva Description and Business Overview
Table 57. Teva Specific Antiviral Drugs for COVID-19 Product
Table 58. Teva Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 59. Teva Recent Development
Table 60. Zydus Cadila Company Details
Table 61. Zydus Cadila Description and Business Overview
Table 62. Zydus Cadila Specific Antiviral Drugs for COVID-19 Product
Table 63. Zydus Cadila Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 64. Zydus Cadila Recent Development
Table 65. Mylan Company Details
Table 66. Mylan Description and Business Overview
Table 67. Mylan Specific Antiviral Drugs for COVID-19 Product
Table 68. Mylan Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 69. Mylan Recent Development
Table 70. Apotex Company Details
Table 71. Apotex Description and Business Overview
Table 72. Apotex Specific Antiviral Drugs for COVID-19 Product
Table 73. Apotex Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 74. Apotex Recent Development
Table 75. Advanz Pharma Company Details
Table 76. Advanz Pharma Description and Business Overview
Table 77. Advanz Pharma Specific Antiviral Drugs for COVID-19 Product
Table 78. Advanz Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 79. Advanz Pharma Recent Development
Table 80. Sun Pharma Company Details
Table 81. Sun Pharma Description and Business Overview
Table 82. Sun Pharma Specific Antiviral Drugs for COVID-19 Product
Table 83. Sun Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 84. Sun Pharma Recent Development
Table 85. Kyung Poong Company Details
Table 86. Kyung Poong Description and Business Overview
Table 87. Kyung Poong Specific Antiviral Drugs for COVID-19 Product
Table 88. Kyung Poong Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 89. Kyung Poong Recent Development
Table 90. Ipca Laboratories Company Details
Table 91. Ipca Laboratories Description and Business Overview
Table 92. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Product
Table 93. Ipca Laboratories Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 94. Ipca Laboratories Recent Development
Table 95. Hanlim Pharmaceutical Company Details
Table 96. Hanlim Pharmaceutical Description and Business Overview
Table 97. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Product
Table 98. Hanlim Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 99. Hanlim Pharmaceutical Recent Development
Table 100. Bristol Laboratories Company Details
Table 101. Bristol Laboratories Description and Business Overview
Table 102. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Product
Table 103. Bristol Laboratories Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 104. Bristol Laboratories Recent Development
Table 105. Bayer Company Details
Table 106. Bayer Description and Business Overview
Table 107. Bayer Specific Antiviral Drugs for COVID-19 Product
Table 108. Bayer Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 109. Bayer Recent Development
Table 110. Rising Pharmaceutical Company Details
Table 111. Rising Pharmaceutical Description and Business Overview
Table 112. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Product
Table 113. Rising Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 114. Rising Pharmaceutical Recent Development
Table 115. Shanghai Pharma Company Details
Table 116. Shanghai Pharma Description and Business Overview
Table 117. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Product
Table 118. Shanghai Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 119. Shanghai Pharma Recent Development
Table 120. Sichuan Sunny Hope Company Details
Table 121. Sichuan Sunny Hope Description and Business Overview
Table 122. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Product
Table 123. Sichuan Sunny Hope Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 124. Sichuan Sunny Hope Recent Development
Table 125. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
Table 126. Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
Table 127. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Product
Table 128. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 129. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
Table 130. CSPC Group Company Details
Table 131. CSPC Group Description and Business Overview
Table 132. CSPC Group Specific Antiviral Drugs for COVID-19 Product
Table 133. CSPC Group Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 134. CSPC Group Recent Development
Table 135. KPC Group Company Details
Table 136. KPC Group Description and Business Overview
Table 137. KPC Group Specific Antiviral Drugs for COVID-19 Product
Table 138. KPC Group Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 139. KPC Group Recent Development
Table 140. Jinghua Pharmaceutical Group Company Details
Table 141. Jinghua Pharmaceutical Group Description and Business Overview
Table 142. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product
Table 143. Jinghua Pharmaceutical Group Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 144. Jinghua Pharmaceutical Group Recent Development
Table 145. Zhongsheng Pharma Company Details
Table 146. Zhongsheng Pharma Description and Business Overview
Table 147. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Product
Table 148. Zhongsheng Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 149. Zhongsheng Pharma Recent Development
Table 150. North China Pharmaceutical Group Company Details
Table 151. North China Pharmaceutical Group Description and Business Overview
Table 152. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product
Table 153. North China Pharmaceutical Group Revenue in Specific Antiviral Drugs for COVID-19 Business 2020 and 2021
Table 154. North China Pharmaceutical Group Recent Development
Table 155. Specific Antiviral Drugs for COVID-19 Market Trends
Table 156. Specific Antiviral Drugs for COVID-19 Market Drivers
Table 157. Specific Antiviral Drugs for COVID-19 Market Challenges
Table 158. Specific Antiviral Drugs for COVID-19 Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Specific Antiviral Drugs for COVID-19 Market Share by Type in 2021 & 2027
Figure 2. Tablet Features
Figure 3. Injection Features
Figure 4. Global Specific Antiviral Drugs for COVID-19 Market Share by Application in 2021 & 2027
Figure 5. Mild Symptom Patient Case Studies
Figure 6. Critically Ill Patient Case Studies
Figure 7. Specific Antiviral Drugs for COVID-19 Report Years Considered
Figure 8. Global Specific Antiviral Drugs for COVID-19 Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 9. Global Specific Antiviral Drugs for COVID-19 Market Share by Regions (2020-2027)
Figure 10. Global Specific Antiviral Drugs for COVID-19 Market Share by Players in 2021
Figure 11. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2021-2027)
Figure 12. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2021-2027)
Figure 13. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Application in 2021
Figure 14. North America Specific Antiviral Drugs for COVID-19 Market Size 2021-2027 (US$ Million)
Figure 15. Europe Specific Antiviral Drugs for COVID-19 Market Size 2021-2027 (US$ Million)
Figure 16. Japan Specific Antiviral Drugs for COVID-19 Market Size 2021-2027 (US$ Million)
Figure 17. Specific Antiviral Drugs for COVID-19 Market Size in China (2021-2027) (US$ Million)
Figure 18. Specific Antiviral Drugs for COVID-19 Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 19. Specific Antiviral Drugs for COVID-19 Market Size in India (2021-2027) (US$ Million)
Figure 20. Bottom-up and Top-down Approaches for This Report
Figure 21. Data Triangulation
Figure 22. Key Executives Interviewed
世界の新型コロナウイルス感染症用医薬品市場規模・現状・予測（2021年-2027年） In 2021, the global COVID-19 Drugs market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global COVID-19 Drugs status, future forecast, growth opportunity, key market, and key players. The stu…- 世界の新型コロナウイルス感染症用中国製医薬品市場規模・現状・予測（2021年-2027年） In 2021, the global Chinese Materia Medica for COVID-19 market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Chinese Materia Medica for COVID-19 status, future forecast, growth opportu…
- 世界の新型コロナウイルス感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Covid-19 Treatments Market The global Covid-19 Treatments market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界の新規抗ウイルス薬市場規模・現状・予測（2021年-2027年） The mechanism of action of antiviral drugs is mainly to inhibit the entry of viral particles into host cells and to inhibit the early stages of viral replication. There is also an inhibitor of DNA polymerase, which is mainly due to its ability to inhibit viral coding. At present, new antiviral drugs…
- 世界のインフルエンザ用抗ウイルス薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Influenza Antiviral Drugs Market The global Influenza Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…